Radiation Oncologists
20 years of experience
Video profile
Accepting new patients
Crescent Park
21st Century Oncology
601 Redstone Ave W
Crestview, FL 32536
Locations and availability (5)

Education ?

Medical School Score Rankings
University of Miami (1990)
Internal Medicine
  • Currently 3 of 4 apples
Top 50%

Awards & Distinctions ?

Florida State University School Of Medicine
American Society of Clinical Oncology
American Board of Radiology
American Society for Therapeutic Radiology and Oncology

Affiliations ?

Dr. Amos is affiliated with 15 hospitals.

Hospital Affilations



  • Sacred Heart Hospital - Emerald Coast
    7800 US Highway 98 W, Miramar Beach, FL 32550
    • Currently 4 of 4 crosses
    Top 25%
  • Twin Cities Hospital
    2190 Highway 85 N, Niceville, FL 32578
    • Currently 4 of 4 crosses
    Top 25%
  • Sacred Heart Hospital - Pensacola
    Medical Oncology
    5151 N 9th Ave, Pensacola, FL 32504
    • Currently 4 of 4 crosses
    Top 25%
  • North Okaloosa Medical Center
    151 E Redstone Ave, Crestview, FL 32539
    • Currently 3 of 4 crosses
    Top 50%
  • West Florida Hospital
    Medical Oncology
    8383 N Davis Hwy, Pensacola, FL 32514
    • Currently 2 of 4 crosses
  • Baptist Hospital
    Medical Oncology
    1000 W Moreno St, Pensacola, FL 32501
    • Currently 1 of 4 crosses
  • Fort Walton Beach Medical Center
    Medical Oncology
    1000 Mar Walt Dr, Fort Walton Beach, FL 32547
    • Currently 1 of 4 crosses
  • Santa Rosa Medical Center
    6002 Berryhill Rd, Milton, FL 32570
    • Currently 1 of 4 crosses
  • Mizell Memorial Hospital
    702 N Main St, Opp, AL 36467
    • Currently 1 of 4 crosses
  • South Baldwin Regional Medical Center
    1613 N McKenzie St, Foley, AL 36535
    • Currently 1 of 4 crosses
  • Healthsouth Emerald Coast Surgery Center
  • Baptist Healthcare Systems
  • West Florida Regional Hospital
  • Baptist Health Care Systems
  • West Florida Reg Med Ctr, Pensacola, Fl
  • Publications & Research

    Dr. Amos has contributed to 3 publications.
    Title Use of Sargramostim As Maintenance Therapy in Patients with Stage Iv Melanoma at High Risk for Systemic Recurrence.
    Date September 2007
    Journal Melanoma Research
    Title Postoperative Radiotherapy for Locally Advanced Colon Cancer.
    Date January 1997
    Journal Annals of Surgical Oncology

    BACKGROUND: The role of adjuvant postoperative radiotherapy for locally advanced colon cancer is not well documented. METHODS: Seventy-eight patients who underwent a complete resection of B2-C colon cancer received postoperative radiotherapy. Twenty-eight patients received < or = 45 Gy; 50 patients received 50-55 Gy. Twenty-seven patients received adjuvant fluorouracil-based chemotherapy. All patients were followed for a minimum of 3 years; no patients were lost to follow-up. RESULTS: The overall local control rate was 88%. The 5-year actuarial rate of local control was 96% after 50-55 Gy postoperative radiotherapy compared with 76% after < 50 Gy (p = 0.0095). Multivariate analysis of local control showed that only radiotherapy dose significantly influenced this end point. Cause-specific survival rates at 5 years were B2, 67%; B3, 90%; C1, 100%; C2, 61%; C3, 36%; and overall, 63%. Multivariate analysis of cause-specific survival showed that only stage significantly influenced this end point. Bowel obstruction caused by adhesions developed in three patients and required a laparotomy; radiation-induced sarcoma developed in one additional patient. CONCLUSIONS: Postoperative radiotherapy appears to reduce the risk of local recurrence in patients with locally advanced colon cancer. The optimal dose is probably 50-55 Gy at 1.8 Gy per fraction. Postoperative radiotherapy may improve cause-specific survival for patients with stages B3 and C2 cancers.

    Title Oropharyngeal Carcinoma Treated with Radiotherapy: a 30-year Experience.
    Date February 1996
    Journal International Journal of Radiation Oncology, Biology, Physics

    PURPOSE: This study was done to determine the outcome in patients with oropharyngeal carcinoma treated at the University of Florida with radiotherapy alone to the primary site, for comparison with reported results of other types of treatment. METHODS AND MATERIALS: Of a consecutive cohort of 785 patients with biopsy-proven, previously untreated, invasive squamous cell carcinoma of the oropharynx, this report is based on the 490 patients who had continuous-course irradiation with curative intent at the University of Florida between October 1964 and January 1991. All patients had a minimum 2-year follow-up. Forty-eight percent had Stage T3 or T4 disease, and 64% had clinically apparent neck node metastases. The median radiation dose was 68 Gy for once-a-day treatment and 76.8 Gy for twice-a-day treatment. Patients with advanced neck node disease had planned neck dissection(s) after radiotherapy. RESULTS: The overall local control rate after radiotherapy alone was 73%. The ultimate local control rate (including surgical salvage) was 78%. At 5 years, the probability of control of neck disease was 85%; control above the clavicles, 67%; absolute survival, 44%; cause-specific survival, 77%; distant metastasis (as the first or only site of failure), 11%. Thirteen patients (2.6%) experienced severe treatment complications. CONCLUSION: Radiotherapy results in tumor control and survival rates comparable with rates achieved with combined irradiation and surgery, with less morbidity.

    Similar doctors nearby

    Dr. James Stevens

    Radiation Oncology
    20 years experience
    Fort Walton Beach, FL

    Dr. William Carroll Hixson

    Radiation Oncology
    20 years experience
    Brewton, AL
    Search All Similar Doctors